BC
GMED icon

Bridgefront Capital’s Globus Medical GMED Stock Holding History

Bridgefront Capital’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-10,778
Closed -$941K – 621
2025
Q4 		$941K Sell
10,778
-864
-7% -$65.6K 0.24% 144
2025
Q3 		$667K Buy
+11,642
New +$670K 0.2% 167
2024
Q2 		– Sell
-6,894
Closed -$370K – 556
2024
Q1 		$370K Buy
+6,894
New +$371K 0.28% 128
2023
Q2 		– Sell
-10,228
Closed -$579K – 546
2023
Q1 		$579K Buy
+10,228
New +$656K 0.35% 69
2022
Q4 		– Sell
-5,758
Closed -$343K – 421
2022
Q3 		$343K Buy
+5,758
New +$347K 0.35% 103
2021
Q3 		– Sell
-2,892
Closed -$224K – 475
2021
Q2 		$224K Sell
2,892
-3,677
-56% -$261K 0.08% 464
2021
Q1 		$405K Buy
+6,569
New +$416K 0.13% 322

Other funds holding GMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bridgefront Capital's GMED Position: Q1 2026 in Review

Bridgefront Capital sold out of Globus Medical (GMED) in Q1 2026, closing a stake of 10,778 shares — an estimated $941K sold.

Bridgefront Capital first reported a position in GMED in Q1 2021 and held it in 7 quarters. The position peaked at $941K in Q4 2025. 602 funds tracked by Wall St. Rank hold GMED as of Q1 2026.

  • Bridgefront Capital reported no remaining Globus Medical position as of Q1 2026 after selling out during the quarter.
  • Bridgefront Capital sold 10,778 Globus Medical shares in Q1 2026, an estimated $941K.
  • Bridgefront Capital first reported a position in Globus Medical in Q1 2021 and held it in 7 quarters.
  • Bridgefront Capital's Globus Medical position peaked at $941K in Q4 2025.
  • 602 funds tracked by Wall St. Rank held Globus Medical as of Q1 2026.

Based on Bridgefront Capital's 13F filing for Q1 2026, filed 15 May 2026.